News and Insights of 3D Printing and Manufacturing
Researchers at Carnegie Mellon University have developed a method of 3D printing microscale ice structures that can be used as sacrificial templates to form intricate channels inside other parts.
Researchers at Carnegie Mellon University have developed a high-speed, reproducible fabrication method that turns the 3D printing process “inside out.” They developed an approach to 3D print ice structures that can be used to create sacrificial templates that later form the conduits and other open features inside fabricated parts.
CELLINK, a global leader in developing 3D bioprinters, and The Indian Institute of Science (IISc) are partnering to establish a Centre of Excellence (CoE) for 3D bioprinting in Bengaluru, India. The CoE, the first of its kind in the sub-continent, will be housed in the Centre for BioSystems Science and Engineering (BSSE) at IISc. The CoE will provide access to 3D bioprinting systems, enabling researchers to accelerate their work across critical applications with the ultimate goal of improving health outcomes.
3D Systems has appointed Dr. Toby Cosgrove, former president and chief executive officer of the Cleveland Clinic, and Dr. Bon Ku, director of the Health Design Lab at Thomas Jefferson University, as the fourth and fifth members of the company’s recently established Medical Advisory Board (MAB). Dr. Cosgrove and Dr. Ku will join former Health & Human Services Secretary Alex Azar, Dr. Stephen K. Klasko, and former US Secretary of Veterans Affairs David J. Shulkin as members of the advisory board. The Board’s primary mission is to provide strategic input, guidance, and recommendations for the company’s expanding efforts in regenerative medicine.
German medical device manufacturer BellaSeno has announced that its proprietary 3D printed breast implants have entered human trials.
A cornea 3D printed at India’s L V Prasad Eye Institute (LVPEI), Indian Institute of Technology (IIT) Hyderabad and Centre for Cellular and Molecular Biology has been successfully animal tested for the first time.
Maritime non-profit Island Missions Support has begun using a Slice Engineering hotend to produce more robust 3D printed prosthetics for amputees in isolated areas of Guatemala.
Prellis Biologics, a biotherapeutics company utilizing its proprietary, high-resolution bioprinting technology to recreate and engineer human tissues in vitro, has appointed Michael Nohaile, PhD as its new CEO, and has raised a $35 million Series C funding round, co-led by Celesta Capital and Avidity Partners with participation from Khosla Ventures, SOSV, True Ventures, and Lucas Venture Group. Dr. Michael Nohaile joins the company from Generate Biomedicines and succeeds Prellis Biologics founder Dr. Melanie Matheu, who will assume the role of Chief Technology Officer and retain a Board seat.
Prellis Biologics has raised $35 million and appointed a new CEO as it seeks to advance the development of its proprietary 3D bioprinted lymph node.
BellaSeno GmbH, an ISO 13485-certified MedTech company developing resorbable chest and breast implant scaffolds using additive manufacturing technologies, began two clinical trials of its products in Australia, which are sponsored by its Australian subsidiary BellaSeno Pty. Already, recruiting has started in Brisbane, Australia.